Education
About Us
Working with TipRanks
Follow Us
Neurotech International Ltd. (AU:NTI)
ASX:NTI
NTI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.09
Previous CloseN/A
Volume11.09K
Average Volume (3M)652.08K
Market Cap
AU$18.89M
Enterprise ValueAU$28.94M
Total Cash (Recent Filing)AU$5.96M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.85
Next Earnings
Aug 27, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding1,049,622,000
10 Day Avg. Volume794,559
30 Day Avg. Volume652,081
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)8.06
Price to Sales (P/S)0.00
P/FCF Ratio-5.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Neurotech International News
PremiumCompany Announcements
Neurotech International Enhances US Presence with New Chief Medical Advisor
PremiumCompany Announcements
Neurotech’s NTI164 to be Highlighted at Rett Syndrome Scientific Meeting
PremiumCompany Announcements
Neurotech International’s NTI164 Shows Promising PK Study Results
PremiumCompany Announcements
Neurotech International Advances in Pediatric Neurological Treatments
PremiumCompany Announcements
Neurotech International Updates Trading Policy to Enhance Compliance
PremiumCompany Announcements
Neurotech International Issues New Shares, Ensures Regulatory Compliance
PremiumCompany Announcements
Neurotech International Expands Share Issuance to Boost Market Position
PremiumCompany Announcements
Neurotech International Announces Director ResignationOptions Prices
Currently, No data available
---
Ownership Overview
0.10% Insiders
―
Mutual Funds
― Other Institutional Investors
99.90% Public Companies and
Individual Investors
NTI FAQ
What was Neurotech International Ltd.’s price range in the past 12 months?
Neurotech International Ltd. lowest share price was AU$0.01 and its highest was AU$0.09 in the past 12 months.
What is Neurotech International Ltd.’s market cap?
Neurotech International Ltd.’s market cap is AU$18.89M.
When is Neurotech International Ltd.’s upcoming earnings report date?
Neurotech International Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 52 days.
How were Neurotech International Ltd.’s earnings last quarter?
Neurotech International Ltd. released its earnings results on Feb 27, 2025. The company reported -AU$0.73 earnings per share for the quarter, missing the consensus estimate of -AU$0.005 by -AU$0.725.
Is Neurotech International Ltd. overvalued?
According to Wall Street analysts Neurotech International Ltd.’s price is currently Overvalued.
Does Neurotech International Ltd. pay dividends?
Neurotech International Ltd. does not currently pay dividends.
What is Neurotech International Ltd.’s EPS estimate?
Neurotech International Ltd.’s EPS estimate is >-0.01.
How many shares outstanding does Neurotech International Ltd. have?
Neurotech International Ltd. has 1,049,622,000 shares outstanding.
What happened to Neurotech International Ltd.’s price movement after its last earnings report?
Neurotech International Ltd. reported an EPS of -AU$0.73 in its last earnings report, missing expectations of -AU$0.005. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Neurotech International Ltd.?
Currently, no hedge funds are holding shares in AU:NTI
Neurotech International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
AU:NTI Sentiment 50%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.00%
12-Months-Change
Fundamentals
Return on Equity
-223.80%
Trailing 12-Months
Asset Growth
26.87%
Trailing 12-Months
Company Description
Neurotech International Ltd.
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.
Technical Analysis
Atomo Diagnostics Ltd.
―
Adherium Ltd.
―
InhaleRx Limited
―
Control Bionics Ltd.
―
OncoSil Medical Ltd
―